Author: Site Editor Publish Time: 08-18-2026 Origin: Site
Facial aging is often a systemic issue, involving multiple dimensions such as volume loss, changes in skin quality, and decreased structural support. As more advanced ingredients become available, people are no longer limited to a single treatment and are increasingly turning to combination approaches that address specific concerns.
For example, hyaluronic acid fillers are well suited to providing immediate volume restoration, while polynucleotides can support long-term collagen regeneration. An hyaluronic acid and polynucleotides combination treatment can address skin rejuvenation from different levels, combining immediate volume restoration with longer-term support for collagen regeneration.
Yes. Emerging research supports the rationale for using HA and PN together. A 2026 Scientific Reports study found synergistic effects when HA and PN were combined in an in vitro model of UVA-damaged dermal fibroblasts. This provides supportive evidence for potential complementary effects.
In practice, the main reason to combine them is that they address different treatment needs. HA is mainly used for volume correction, while PN may be considered when skin quality is also a concern.
Concern Type | Common Concerns |
Volume-related concerns | Cheek volume loss, temple hollowing, tear troughs, reduced jawline definition |
Skin-quality concerns | Rough texture, dull-looking skin, reduced elasticity, fine lines and wrinkles |
The goal is not to combine HA and PN routinely. Treatment should be based on the patient's anatomy, skin condition, treatment goals, and the indications of the selected products.
There are three main approaches. The appropriate option depends on the patient's needs and the practitioner's treatment plan.
A pre-mixed injectable product contains both HA and PN in a single formulation.
This may be considered when both skin quality and mild volume enhancement are treatment goals. The main limitation is that the formulation is fixed, so the HA and PN components cannot be adjusted independently. Patients with greater volume loss may require a separate HA filler, depending on the product indication.
Hyaluronic acid and polynucleotides can be used in different treatment areas or tissue planes within the same treatment plan. For example, HA may be used in a deeper plane for structural support and volume correction, while PN may be administered more superficially to address skin quality.
This approach may suit patients who have both significant volume loss and skin-quality concerns. It requires appropriate knowledge of facial anatomy, injection planes, product indications, and dosing.
HA and PN can also be used in separate treatment sessions. For example, PN may be introduced first when skin quality is the main concern, followed by HA when additional volume correction is needed.
This approach gives the practitioner more flexibility to assess the patient's response before moving to the next treatment. It may be useful for patients who prefer a step-by-step, longer-term treatment plan.
HA and PN combination treatment reflects a broader shift toward combination approaches in aesthetic practice. Rather than relying on one product for every concern, practitioners can select different treatments according to the patient's pattern of facial aging and skin condition.
For distributors and aesthetic practices, the key is not simply offering more products, but understanding which combination fits which patient.
If you have questions about product selection, treatment planning, or injection techniques, feel free to contact us for further consultation.
